For pharmaceutical and biopharmaceutical companies that need quick access to evidence to inform a decision, we offer targeted reviews of secondary data. Our experts can capture current evidence related to a specific tumor type, drug or market, and then supply our findings in a self-service format, such as a web portal or a customized report.
- Systematic literature review
- Guidelines review and assessment
- Conference proceedings and publications review